Synthesis of potential peptidomimetics based on highly substituted glucose and allose scaffolds

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 16, 1996, Pages 1983-1988

  Le Diguarher, Thierry ^a   Boudon, Alain ^a   Elwell, Claire ^b   Paterson, Duncan E ^a   Billington, David C ^b  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE DERIVATIVE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; INDOLE DERIVATIVE;

ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; INTRACEREBRAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; STRUCTURE ACTIVITY RELATION;

EID: 0030594984     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00336-8     Document Type: Article

References (34)

1. 1) a) Giannis, A.; Kolter, T. Angew. Chem. Int. Ed. Engl., 1993, 32, 1244.;
2. b) Hirschmann, R.; Nicolaou, K.C.; Pietranico, S.; Salvino, J.; Leahy, E.M.; Sprengeler, P.A.; Furst, G.; Smith, A.B. III; Strader, C.; Cascieri, M.A.; Candelore, M.R.; Donaldson, C.; Vale, W.; Maechler, L. J. Am. Chem. Soc., 1992, 114, 9217.;
3. c) Hirschmann, R.; Sprengeler, P.A.; Kawasaki, T.; Leahy, J.W.; Shakspeare, W.C.; Smith, A.B. III J. Am. Chem. Soc., 1992, 114, 9699.;
4. d) Papageorgiou, C.; Haltiner, R.; Bruns, C.; Petcher, T.J. Biomed. Chem. Lett., 1992, 2, 135.
5. 2) Clozel, M.; Watanabe, H. Life Sci., 1993, 52, 825.
6. 3) a) Atkinson, R.A.; Pelton, J.T. FEBS Lett, 1992, 296, 1.;
7. b) Krystek, S.R. Jr; Bassolino, D.A.; Bruccoleri, R.E.; Hunt, J.T.; Porubcan, M.A.; Wandler, C.F.; Andersen, N.H. FEBS Lett, 1992, 299, 255.;
8. c) Reily, M.D.; Thanabal, V.; Omecinski, D.O.; Dunbar, J.B.; Doherty, A.M.; DePue, P.L. FEBS Lett, 1992, 300, 136.;
9. d) Coles, M.; Sowemimo, V.; Scanlon, D.; Munro, S.L.A.; Craik, D.J. J. Med. Chem., 1993, 36, 2658.;
10. e) Moreland, S. Cardiovascular Drug Rev., 1994, 12, 48.
11. 4) Molecular Modelling was performed with the SYBYL software package version 5.4 (Tripos Associates St Louis , MO.) running on a Silicon Graphics indigo R4000 workstation.
12. 5) Czernecki, S.; Georgoulis, C.; Provelenghiou, C. Tetrahedron Lett., 1976, 3535.
13. 6) Charette, A. B.; Marcoux, J. F.; Côté, B. Tetrahedron Lett., 1991, 32, 7215.
14. 7) Herscovici, J.; Antonakis, K. J. Chem. Soc. Chem. Commun., 1980, 561.
15. 8) Baker, D. C.; Horton, D.; Tindall, C. G. Carbohydr. Res., 1970, 24, 192.
16. 9) Finan, P. A.; Warren, C. D. Carbohydr. Res., 1962, 3089.
17. 10) Yields given for multiple examples of identical transformations (e.g. 5a-d -> 6a-d) are average values
18. 11) Schroeder L. R.; Green J. W. J. Chem. Soc., (C), 1966, 530.
19. 12) Lacombe, J. M.; Rakotomanomane, N.; Pavia, A. A. Carbohydr. Res., 1988, 181, 246.
20. 13) Zemplen ; Gerecs Ber. 1934, 67, 2049.
21. 14) Bundle, D. R. J. Chem. Soc. Perkin Trans I, 1979, 2751.
22. 15) Hart, D. J.; Hong, W. P., Hsu, L. Y. J. Org. Chem., 1987, 52, 4665.
23. 16) Petasis, N. A.; Bzowej, E. I. J. Am. Chem. Soc., 1990, 112, 6392, .
24. 17) Csuk, R.; Glänzer, B. I. Tetrahedron, 1991, 47, 1655, .
25. 18) Le Diguarher, T.; Billington, D. C.; Dorey, G. Synth. Commun., 1995, 25, 1633
26. 19) Szarek, W. A.; Zamojski, A.; Tiwari, K. N.; Ison, E. R. Tetrahedron Lett., 1986, 27, 3827 .
27. 20) Malanga, C. Chem. Ind., 1987, 856.
28. 21) Mitsunobu, O. Synthesis, 1981, 1.
29. 22) Csuk, R.; Hönig, H.; Nimpf, J.; Weidmann, H.Tetrahedron Lett. 1980, 21, 2135.
30. 23) a) Illi, V. O. Synthesis, 1979, 387.
31. b) Neutzescu, C. D.; Raileanu, D. Chem. Ber., 1958, 91, 114.
32. 24) Winters, R. T.; Sercel, A. D.; Hollis-Showalter, H. D. Synthesis, 1988, 712.
33. 13C NMR, mass spectral, and elemental analysis data, in full agreement with their assigned structures.
34. B receptors by CEREP, Le Bois l'Eveque, BP-1 Celle l'Evescault, France, 86600.